Detalhe da pesquisa
1.
Efficacy of idelalisib and rituximab in relapsed/refractory chronic lymphocytic leukemia treated outside of clinical trials. A report of the Gimema Working Group.
Hematol Oncol
; 39(3): 326-335, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-33739461
2.
The classic prognostic factors in advanced Hodgkin's lymphoma patients are losing their meaning at the time of Pet-guided treatments.
Ann Hematol
; 99(2): 277-282, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-31872362
3.
Correction to: The classic prognostic factors in advanced Hodgkin's lymphoma patients are losing their meaning at the time of pet-guided treatments.
Ann Hematol
; 100(1): 303-304, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-33219839
4.
Lenalidomide plus R-CHOP21 in elderly patients with untreated diffuse large B-cell lymphoma: results of the REAL07 open-label, multicentre, phase 2 trial.
Lancet Oncol
; 15(7): 730-7, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24831981
5.
Safety and efficacy of lenalidomide in combination with rituximab in recurrent indolent non-follicular lymphoma: final results of a phase II study conducted by the Fondazione Italiana Linfomi.
Haematologica
; 101(5): e196-9, 2016 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-26858355
6.
Allogeneic stem cell transplantation in patients with mantle cell lymphoma: results from the MANTLE-FIRST study on behalf of Fondazione Italiana Linfomi.
Leuk Lymphoma
; 62(14): 3474-3483, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34625013
7.
ROBUST: A Phase III Study of Lenalidomide Plus R-CHOP Versus Placebo Plus R-CHOP in Previously Untreated Patients With ABC-Type Diffuse Large B-Cell Lymphoma.
J Clin Oncol
; 39(12): 1317-1328, 2021 04 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-33621109
8.
Obinutuzumab and miniCHOP for unfit patients with diffuse large B-cell lymphoma. A phase II study by Fondazione Italiana Linfomi.
J Geriatr Oncol
; 11(1): 37-40, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31296461
9.
Applying Data Warehousing to a Phase III Clinical Trial From the Fondazione Italiana Linfomi Ensures Superior Data Quality and Improved Assessment of Clinical Outcomes.
JCO Clin Cancer Inform
; 3: 1-15, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31633999
10.
Early autologous stem-cell transplantation versus conventional chemotherapy as front-line therapy in high-risk, aggressive non-Hodgkin's lymphoma: an Italian multicenter randomized trial.
J Clin Oncol
; 21(7): 1255-62, 2003 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-12663712
11.
Fludarabine plus mitoxantrone with and without rituximab versus CHOP with and without rituximab as front-line treatment for patients with follicular lymphoma.
J Clin Oncol
; 22(13): 2654-61, 2004 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-15159414
12.
Role of anemia in survival of patients with elderly aggressive non-Hodgkin's lymphoma after chemotherapy.
Leuk Lymphoma
; 46(10): 1449-54, 2005 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-16194890
13.
Stem cell mobilization after bendamustine in indolent lymphomas: a multicenter study on behalf of the Fondazione Italiana Linfomi.
Bone Marrow Transplant
; 55(12): 2350-2353, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32541690
14.
B-cell compartment as the selective target for the treatment of immune thrombocytopenias.
Haematologica
; 88(5): 538-46, 2003 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-12745273
15.
Effectiveness of fludarabine, idarubicin and cyclophosphamide (FLUIC) combination regimen for young patients with untreated non-follicular low-grade non-Hodgkin's lymphoma.
Leuk Lymphoma
; 45(9): 1815-9, 2004 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-15223641
16.
Lenalidomide in combination with dexamethasone in elderly patients with advanced, relapsed or refractory multiple myeloma and renal failure.
Mediterr J Hematol Infect Dis
; 5(1): e2013037, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23795275
17.
Ifosfamide, epirubicin and etoposide regimen as salvage and mobilizing therapy for relapsed/refractory lymphoma patients.
Haematologica
; 87(8): 816-21, 2002 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-12161357